相关实验视频

Updated: May 17, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

HER2阳性胃癌:从向治疗到CAR-T细胞治疗

Qiangzu Shao^1,2, Junge Deng^1,2, Haoran Wu^1,2

¹The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.

Frontiers in immunology

|April 4, 2025

概括

HER2阳性胃癌 (GC) 对化疗反应有限. 新型疗法,如抗体-药物联合体和CAR-T细胞提供了新的选择,但耐药性仍然是针对HER2向治疗的挑战.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症治疗方法癌症治疗方法

背景情况:

胃癌 (GC) 是一个全球性的健康问题,HER2-阳性GC带来了独特的挑战.
传统化疗对HER2阳性GC的疗效有限.
分子向疗法的进步为这种亚型提供了新的希望.

研究的目的:

总结目前的HER2向治疗胃癌的策略.
审查HER2向治疗GC药物耐药性的机制.
讨论克服抵抗的潜在未来方向.

主要方法:

对胃癌的HER2向治疗方法的综合文献综述.
分析与抗体-药物合物 (ADC) 和仿制抗原受体T细胞 (CAR-T) 疗法相关的耐药性机制.
讨论新兴的治疗策略及其临床影响.

主要成果:

包括ADC和CAR-T在内的针对HER2的疗法已经成为对HER2阳性GC的有希望的治疗方法.
瘤异质性和瘤微环境是导致药物耐药性的关键因素.
各种耐药机制限制了当前针对HER2的方法的长期有效性.

结论:

尽管取得了进展,但克服耐药性对于改善HER2阳性GC患者的结果至关重要.
了解抵抗机制对于开发更有效的治疗策略至关重要.
未来的研究应该专注于组合疗法和新的方法,以提高针对HER2的治疗疗效.

关键词:

在HER2中,HER2是HER2.细胞治疗疗法细胞治疗疗法药物耐药性耐药性药物耐药性胃癌胃癌是一种胃癌.有针对性的治疗.

更多相关视频

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...